Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yuan, Ang ^a   Hsiao, Yi Jing ^b   Chen, Hsuan Yu ^c   Chen, Huei Wen ^b   Ho, Chao Chi ^a   Chen, Yu Yun ^a   Liu, Yi Chia ^d   Hong, Tsai Hsia ^a,b   Yu, Sung Liang ^b   Chen, Jeremy J W ^e   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^d NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CLUSTER ANALYSIS; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; KAPLAN MEIER METHOD; LUNG TUMOR; MACROPHAGE; MALE; METABOLISM; MORTALITY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMARKERS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CLUSTER ANALYSIS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MACROPHAGES; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84942092284     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14273     Document Type: Article

References (45)

1. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005)
2. Joyce, J. A. &Pollard, J. W. Microenvironmental regulation of metastasis. Nat Rev Cancer 9, 239-252 (2009)
3. Hanahan, D. &Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011)
4. Solinas, G., Germano, G., Mantovani, A. &Allavena, P. Tumor-Associated macrophages (TAM) as major players of the cancerrelated inflammation. J Leukoc Biol 86, 1065-1073 (2009)
5. Qian, B. Z. &Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010)
6. Mantovani, A., Schioppa, T., Porta, C., Allavena, P. &Sica, A. Role of tumor-Associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25, 315-322 (2006)
7. Tjiu, J. W. et al. Tumor-Associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol 129, 1016-1025 (2009)
8. Kawai, O. et al. Predominant infiltration of macrophages and CD8(+ ) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 113, 1387-1395 (2008)
9. Welsh, T. J. et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23, 8959-8967 (2005)
10. da Costa Souza, P. et al. Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma. Histopathology 61, 587-596 (2012)
11. Chen, J. J. et al. Tumor-Associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 23, 953-964 (2005)
12. Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A. &Bradding, P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J 33, 118-126 (2009)
13. Biswas, S. K. &Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11, 889-896 (2010)
14. Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677-686 (2004)
15. Ma, J. et al. The M1 form of tumor-Associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 10, 112 (2010)
16. Zhang, B. et al. M2-polarized tumor-Associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics (Sao Paulo) 66, 1879-1886 (2011)
17. Murdoch, C., Muthana, M., Coffelt, S. B. &Lewis, C. E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8, 618-631 (2008)
18. Jinushi, M. et al. Tumor-Associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci USA 108, 12425-12430 (2011)
19. Zhang, B. et al. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem 107, 134-143 (2009)
20. Zaynagetdinov, R. et al. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol 187, 5703-5711 (2011)
21. Shedden, K. et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14, 822-827 (2008)
22. Robinson, B. D. et al. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15, 2433-2441 (2009)
23. Chen, J. J. et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 9, 729-737 (2003)
24. Mukhtar, R. A., Nseyo, O., Campbell, M. J. &Esserman, L. J. Tumor-Associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 11, 91-100 (2011)
25. Rolny, C. et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19, 31-44 (2011)
26. Mantovani, A. &Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22, 231-237 (2010)
27. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. &Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3, 991-998 (2002)
28. Sica, A., Schioppa, T., Mantovani, A. &Allavena, P. Tumour-Associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42, 717-727 (2006)
29. Luo, Y. P. et al. The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene 29, 662-673 (2010)
30. Konstantopoulos, K. &Thomas, S. N. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 11, 177-202 (2009)
31. Miyazono, K., Ehata, S. &Koinuma, D. Tumor-promoting functions of transforming growth factor-beta in progression of cancer. Ups J Med Sci 117, 143-152 (2012)
32. Yuan, Y. et al. Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis. Lung Cancer 66, 28-36 (2009)
33. Yoshioka, N., Wang, L., Kishimoto, K., Tsuji, T. &Hu, G. F. A therapeutic target for prostate cancer based on angiogeninstimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA 103, 14519-14524 (2006)
34. Demidova, A. R., Aau, M. Y., Zhuang, L. &Yu, Q. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control. J Biol Chem 284, 4132-4139 (2009)
35. St Germain, C. et al. Cisplatin induces cytotoxicity through the mitogen-Activated protein kinase pathways and activating transcription factor 3. Neoplasia 12, 527-538 (2010)
36. Taguchi, T. et al. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Oncol Rep 11, 421-426 (2004)
37. Sheikh, M. S. et al. Identification of several human homologs of hamster DNA damage-inducible transcripts. Cloning and characterization of a novel UV-inducible cDNA that codes for a putative RNA-binding protein. J Biol Chem 272, 26720-26726 (1997)
38. Oyadomari, S. &Mori, M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11, 381-389 (2004)
39. Lee, Y. Y., Cevallos, R. C. &Jan, E. An upstream open reading frame regulates translation of GADD34 during cellular stresses that induce eIF2alpha phosphorylation. J Biol Chem 284, 6661-6673 (2009)
40. Zerbini, L. F. et al. NF-kappa B-mediated repression of growth arrest-And DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci USA 101, 13618-13623 (2004)
41. Smith, M. L. et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266, 1376-1380 (1994)
42. Novakova, Z. et al. Cytokine expression and signaling in drug-induced cellular senescence. Oncogene 29, 273-284 (2010)
43. Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031 (2008)
44. Lin, S. Y. et al. HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma. Nucleic Acids Res 38, 6148-6158 (2010)
45. Chen, H. Y. et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356, 11-20 (2007)